Combination treatment efficient for high astigmatism correction

Article

Combined toric lens implantation and astigmatic keratotomy is a safe and effective way to correct high astigmatism, according to findings published in Techniques in Ophthalmology.

Combined toric lens implantation and astigmatic keratotomy is a safe and effective way to correct high astigmatism, according to findings published in Techniques in Ophthalmology.

Dr Robert H. Osher et al., Cincinnati Eye Institute, Cincinnati, Ohio, USA, studied 20 eyes with keratometric astigmatism with a mean of 4.05 D. All patients were implanted with a toric IOL combined with astigmatic keratotomy. The outcome measure was uncorrected distance visual acuity (UDVA).

All patients attained a UDVA of 20/40 or better. Of the 20 eyes studied, 8 eyes achieved a UDVA of 20/25 or better and 16 eyes achieved 1 D or less of refractive cylinder. Additionally, no complications occurred either intra- or postoperatively and the full group indicated satisfaction with their visual results.

The results demonstrated that through combining toric IOL implantation and astigmatic keratotomy it is possible to reduce high astigmatism in cataract patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.